ADMS Adamas Pharmaceuticals, Inc.

15.62
0  0%
Previous Close 15.67
Open 15.70
Price To book 2.61
Market Cap 347.06M
Shares 22,219,000
Volume 150,060
Short Ratio 29.44
Av. Daily Volume 123,027

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data released early June 2016. Evaluating Phase 3 pathway.
ADS-5102
Multiple sclerosis (MS)
Approved December, 24 2014.
Namzaric
Moderate to severe dementia of the Alzheimer's type.
PDUFA date August 24, 2017.
ADS-5102
Levodopa-Induced Dyskinesia

Latest News

  1. Adamas Announces Oral and Poster Presentations of ADS-5102 Pooled Phase 3 Data at the 69th American Academy of Neurology Annual Meeting
  2. Adamas Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ADMS-US : April 5, 2017
  3. Adamas Announces Data Presentation on ADS-5102 at the Academy of Managed Care Pharmacy 2017 Annual Meeting
  4. Adamas to Present at the 16th Annual Needham Healthcare Conference
  5. Adamas Pharmaceuticals, Inc. :ADMS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
  6. Are These 2 Biotechs Diamonds in the Rough?
  7. Adamas Pharmaceuticals, Inc. :ADMS-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
  8. Adamas Announces New Employment Inducement Grant
  9. Adamas Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ADMS-US : March 10, 2017
  10. Adamas to Present at the 37th Annual Cowen Health Care Conference
  11. Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2016
  12. Adamas Presents Additional Open-Label, Long-Term Safety and Efficacy Data on ADS-5102 at the First Pan American Parkinson’s Disease and Movement Disorders Congress
  13. Adamas to Present New ADS-5102 Data from Phase 2 Trial in Walking Impairment Associated with Multiple Sclerosis at ACTRIMS Forum 2017
  14. Adamas Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ADMS) : January 20, 2017
  15. Adamas Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ADMS-US : January 19, 2017
  16. Adamas Pharmaceuticals Inc (ADMS) Is Up On PDUFA: What’s Next?
  17. Adamas Pharmaceuticals (ADMS) in Focus: Stock Up 5.4%